Filter
313
Filtered Results: 313
Text search:
dexaméthasone
Featured
Recommendations
51
New Publications
68
Language
Document type
No document type
137
Guidelines
100
Studies & Reports
29
Manuals
22
Fact sheets
8
Training Material
7
Strategic & Response Plan
5
Resource Platforms
2
Infographics
2
Situation Updates
1
Countries / Regions
India
27
Brazil
12
Ethiopia
12
Kenya
10
Rwanda
10
Latin America and the Carribbean
9
Paraguay
9
Nepal
8
Mozambique
7
Germany
7
Senegal
6
Bangladesh
6
Indonesia
6
Global
5
South Africa
5
Nigeria
4
Guinea-Bissau
4
Congo, Democratic Republic of
4
Bolivia
4
Argentina
4
Uganda
4
Angola
4
Cameroon
3
Syria
3
Malawi
3
Africa
3
Haiti
3
Tanzania
3
West and Central Africa
3
Russia
3
Zambia
3
Liberia
3
Myanmar / Burma
3
El Salvador
2
Ghana
2
Chile
2
Burkina Faso
2
Zimbabwe
2
Middle East and North Africa
2
East and Southern Africa
2
Namibia
2
South Sudan
2
Colombia
1
Ukraine
1
Benin
1
Sierra Leone
1
Gambia
1
Fiji
1
Malaysia
1
Philippines
1
Guinea
1
Cambodia
1
Venezuela
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Côte d’Ivoire / Ivory Coast
1
Yemen
1
Mali
1
Libya
1
Bhutan
1
Botswana
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
191
Clinical Guidelines
47
Women & Child Health
16
Public Health
4
Key Resources
3
Pharmacy & Technologies
1
Toolboxes
COVID-19
79
Pharmacy
32
TB
19
Caregiver
8
Mental Health
7
NTDs
7
Conflict
7
AMR
4
Rapid Response
3
HIV
3
Global Health Education
3
Planetary Health
2
Disability
1
Ebola
1
Health Financing Toolbox
1
NCDs
1
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
Guidelines on Management of COVID-19 in Kenya
recommended
It has been over a year since Kenya identified the first case of COVID-19 in the country. The Government formed the National COVID-19 task force, which supported the country's response through multi-sectoral technical working groups on testing, case management, risk communication and community engag...
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
Kenya Quality Model for Health - Health Facilities
Glaucoma, a disease that gradually affects the optic nerve, is the second leading cause of vision loss globally, and it continues to pose a challenge to the eye health professionals.
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Guía de tratamiento farmacológico y manejo deescenarios clínicos de casos de COVID-19 – enero 2022 Guía de tratamiento farmacológico y manejo deLeer más
This is the first edition of Empiric Antibiotic Guidelines, as a guidance to all medical practitioners at North Okklapa General & Teaching Hospital.
Antibiotics are critical in the management of infection and can have a significant impact in reducing morbidity and mortality. Emerging antimicrobia...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
MSF الإرشادات السريرية. دليل التشخيص والعلاج
recommended
Clinical Guidelines. Diagnosis and Treatment Manual.
The pharmaceutical sector of any nation is responsible for providing society with quality medicines and other pharmaceutical services. According to the World Health Organization (WHO), Pharmaceuticals may constitute as much as 40% of the national health budget in developing countries, yet portions o...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Le syndrome respiratoire aigu provoqué par le coronavirus-2 (SARS-CoV-2), initialement décrit en Chine, est responsable
de la pandémie que nous connaissons actuellement sous le nom de coronavirus disease 2019 ou COVID-19. L'épidémie de
coronavirus a été déclarée « urgence de santé publi...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
